Chemical Biology: Enabling Drug Discovery

Chemical biology and proteomics strategies have rapidly emerged as cost effective yet powerful preclinical approaches for the discovery and identification of novel drugs and targets. Advances in the development and combination of novel chemical tools, bioorthogonal techniques, disease-relevant phenotypic systems, chemoinformatics, and chemical proteomics now provide robust and high-throughput workflows for interrogating drug-target-phenotype relationships. These efforts are poised to significantly enrich preclinical discovery programs and are illuminating a new paradigm for the development of novel drugs modulating novel targets.

  • Chemical genetic approach: Small molecule probes
  • Applications for activity-based probes in drug discovery
  • Chemical biology of stem cell modulation
  • Chemical biology of histone modifications
  • Chemologics
  • Antibody-Drug conjugates in oncology
  • Drug discovery by DNA-encoded libraries
  • Chemical biology in regenerative medicine
  • Nanotechnology
  • Highthroughput screening

Related Conference of Chemical Biology: Enabling Drug Discovery

August 11-12, 2026

5th World Congress on Plasma Chemistry and Plasma Processing

Amsterdam, Netherlands
September 14-15, 2026

22nd European Organic Chemistry Congress

Rome, Italy
September 21-22, 2026

16th International Chemistry Congress

Barcelona, Spain
November 23-24, 2026

15th World Congress on Biopolymers and Biomaterials

Paris, France
November 26-27, 2026

6th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands
January 18-19, 2027

9th Global Summit on Polymer Chemistry

Paris, France
February 25-26, 2027

17th International Conference on Chemistry Meeting

Paris, France
June 24-25, 2027

16th World Congress on Chromatography

Paris, France

Chemical Biology: Enabling Drug Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in